Black Diamond Therapeutics, Inc. BDTX
1.74 USD +0.08 (+4.52%)
At closeNov 9, 2026, 4:00 AM EST
1.73 -0.01 -0.29%
Pre-market · Nov 9, 4:00 AM ET
1.64 Day range 1.79
1.60 52-week range 4.94
- YTD
- -28.60%
- 1 year
- -56.41%
News
seekingalpha.com Black Diamond Therapeutics: Delay In Trial Results Leads To A Downgrade, But It's Still A Buy I am downgrading Black Diamond Therapeutics from Strong Buy to 'Buy' due to slower-than-expected phase 3 initiation for silevertinib in 1st-line non-classical EGFRm NSCLC. BDTX's silevertinib…
benzinga.com HC Wainwright & Co. Reiterates Buy on Black Diamond Therapeutic, Maintains $11 Price Target HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11 price target.